Remove Bacteria Remove Production Remove Reagent
article thumbnail

BioSpace Global Roundup: Ipsen Wins Fast Track Designation for Cancer Drug and More

The Pharma Data

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. Vivlion holds an exclusive license to Goethe University of Frankfurt’s proprietary 3Cs technology for the production of next generation 3Cs CRISPR/Cas gRNA libraries. Financial details of the agreement were not disclosed. in Mainland China.

Drugs 52
article thumbnail

Biopharma Update on the Novel Coronavirus: October 20

The Pharma Data

Warning Letter: The FDA and the FTC issued a warning letter to For Our Vets LLC dba Patriot Supreme for selling products with fraudulent COVID-19 claims. DB ( Becton, Dickinson and Company ) received a CE mark for its BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes for assessing immune function in COVID-19 patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery. Growth Programme.

article thumbnail

Global Roundup: EU Approves ViiV’s HIV-1 Drug and More

The Pharma Data

The agreement includes a £500,000 upfront payment to Avacta which gives Astrea the rights to generate and develop Affimer reagents in-house for affinity separation. Peijia received an exclusive license regarding certain proprietary TMVR products currently in development by HighLife. It is a division of Gamma Biosciences.

Drugs 52
article thumbnail

Rising Demand for DNA and Gene Cloning  Service Providers

Roots Analysis

The process of DNA cloning / gene cloning needs to be monitored closely to ensure high-quality and stable finished product. Further, the labor and reagent cost incurred in cloning procedures is reduced with customized cloning. However, this often affects protein purification and expression.

DNA 40
article thumbnail

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Roots Analysis

The following figure presents the schematic representation of protein expression from design to large scale production. Recent protein expression market trends showcase a growing emphasis on cell free protein expression systems, advanced bioinformatics, and the rise of the protein expression market for kits and reagents.

Protein 40